| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2000 | WO2000009148A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000008924A1 Method of performing transgenesis |
| 02/24/2000 | WO2000008920A1 Polynucleotides controlling the expression of and coding for gene b in tomato |
| 02/24/2000 | WO2000003581A8 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
| 02/24/2000 | WO2000003024A3 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 02/24/2000 | WO2000003013A3 Gene and protein involved in liver regeneration |
| 02/24/2000 | WO2000001824A3 Method for genetic engineering of disease resistance using the drr206 class of proteins |
| 02/24/2000 | WO2000001820A3 Nucleic acid molecules encoding nuclear hormone receptor coactivators, and uses thereof |
| 02/24/2000 | WO2000001808A3 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
| 02/24/2000 | WO2000001804A3 Nucleotide sequence encoding a protein with beta glucanase activity and use thereof |
| 02/24/2000 | WO1999067375A3 Screening system |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999065461A3 Cationic amphiphile micellar complexes |
| 02/24/2000 | WO1999064432A3 Multi-fluorescent hairpin energy transfer oligonucleotides |
| 02/24/2000 | WO1999061814A9 Mechanical lock with a cam-driven locking pawl |
| 02/24/2000 | WO1999061605A9 System for reproducing and modulating stability and turnover of rna molecules |
| 02/24/2000 | WO1999061597A9 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter |
| 02/24/2000 | WO1999060111A9 Genetics-assisted target evaluation in antibacterial drug discovery |
| 02/24/2000 | WO1999060096A9 Oxygenase enzymes and screening method |
| 02/24/2000 | WO1999060011A9 Secretion of toxins by gram-negative bacteria |
| 02/24/2000 | WO1999059638A3 Compositions and methods for the delivery of nucleic acid molecules |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999058685A3 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999058098A8 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 02/24/2000 | WO1999057133A3 Inhibitors of nf-kb activation |
| 02/24/2000 | WO1999055891A8 Plant gene that regulates dna methylation |
| 02/24/2000 | WO1999055885A3 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein |
| 02/24/2000 | WO1999055857A3 Nucleoside triphosphates and their incorporation into ribozymes |
| 02/24/2000 | WO1999053046A3 Noncloning technique for expressing a gene of interest |
| 02/24/2000 | WO1999051722A3 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same |
| 02/24/2000 | WO1999049774A9 Methods for the diagnosis and treatment of lung cancer |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | WO1999043797A3 Constitutive maize promoters |
| 02/24/2000 | WO1999042586A3 Exo1 and exo2, exocytotic proteins |
| 02/24/2000 | WO1999009139A9 Retrovirus and viral vectors |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | DE19836774A1 Protein und DNA-Sequenz der Pinosylvin-3-0-methyltransferase (PMT) Protein and DNA sequence of the pinosylvin-3-0-methyltransferase (PMT) |
| 02/24/2000 | DE19836382A1 Neues Tiermodell zur Entstehung und Therapie von Diabetes Mellitus New animal model for the pathogenesis and therapy of diabetes mellitus |
| 02/24/2000 | DE19834612A1 Verfahren zum intrazellulären Transfer von Oligonukleotiden und Vorrichtung zur Durchführung desselben Of the same method for the intracellular transfer of oligonucleotides and apparatus for performing |
| 02/24/2000 | DE19828624C1 Modular aufgebaute RNA-Moleküle mit zwei Sequenzbereichstypen Modular RNA molecules with two types of sequence region |
| 02/24/2000 | CA2349852A1 Method for recovering proteins from the interstitial fluid of plant tissues |
| 02/24/2000 | CA2348388A1 Gene regulating circadian clock function and photoperiodism |
| 02/24/2000 | CA2348152A1 Vessel for withdrawing blood |
| 02/24/2000 | CA2341029A1 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | CA2340744A1 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340428A1 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | CA2340392A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | CA2340322A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | CA2340242A1 Method of performing transgenesis |
| 02/24/2000 | CA2340199A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/24/2000 | CA2340181A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
| 02/24/2000 | CA2340153A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
| 02/24/2000 | CA2340095A1 Canine growth hormone secretagogue receptor |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2340075A1 Apparatus and method for the delivery of drugs and genes into tissue |
| 02/24/2000 | CA2339948A1 Novel amplicon in the 20q13 region of human chromosome 20 and uses thereof |
| 02/24/2000 | CA2339904A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339524A1 Cyp3a4 nfse variant and methods of use therefor |
| 02/24/2000 | CA2339518A1 Gene |
| 02/24/2000 | CA2339420A1 Domain specific gene evolution |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339414A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339350A1 High level secretory expression system of intact mk family protein |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2339302A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339088A1 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339041A1 Construction of normalized cdna libraries from eucaryotic cells |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2338015A1 Genes for detecting bacteria and a method for detecting bacteria by using the genes |
| 02/24/2000 | CA2335651A1 Gene switch |
| 02/24/2000 | CA2335647A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
| 02/24/2000 | CA2334946A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 02/24/2000 | CA2333914A1 Dna shuffling to produce herbicide selective crops |
| 02/24/2000 | CA2333901A1 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| 02/24/2000 | CA2333832A1 Pesticidal toxins and genes from bacillus laterosporus strains |
| 02/24/2000 | CA2332615A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
| 02/24/2000 | CA2332105A1 Maize rad6 genes and uses thereof |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980912A1 Alkaline ceramidase (E.C. 3.5.1.23) gene from Pseudomonas aeruginosa |
| 02/23/2000 | EP0980911A2 Phosphodiesterase |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980524A1 Detection of molecular interactions by reporter subunit complementation |
| 02/23/2000 | EP0980436A1 Increased production of proteins by using chaperone-like proteins |